Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Augusto Miravalle

Concepts (87)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
9
2021
376
1.270
Why?
Immunosuppressive Agents
5
2021
646
1.190
Why?
Multiple Sclerosis, Relapsing-Remitting
5
2021
69
1.160
Why?
Nervous System Diseases
3
2015
256
1.050
Why?
Cladribine
1
2021
2
0.740
Why?
Vaccines
2
2014
375
0.550
Why?
Encephalomyelitis, Acute Disseminated
2
2009
13
0.550
Why?
Demyelinating Diseases
2
2019
75
0.540
Why?
Clinical Coding
1
2016
19
0.530
Why?
Office Visits
1
2016
79
0.520
Why?
International Classification of Diseases
1
2016
116
0.500
Why?
Immunologic Factors
5
2020
220
0.470
Why?
Immune Reconstitution Inflammatory Syndrome
2
2012
18
0.460
Why?
Vaccination
2
2014
1204
0.450
Why?
Natalizumab
6
2021
46
0.440
Why?
4-Aminopyridine
1
2011
21
0.370
Why?
Gait Disorders, Neurologic
1
2011
41
0.360
Why?
Managed Care Programs
1
2011
133
0.350
Why?
Antibodies, Monoclonal
3
2010
1264
0.340
Why?
Benchmarking
1
2011
161
0.340
Why?
Yellow Fever Vaccine
1
2009
6
0.340
Why?
Multiple Sclerosis, Chronic Progressive
2
2021
25
0.310
Why?
Telemedicine
1
2016
662
0.300
Why?
Leukoencephalopathy, Progressive Multifocal
2
2020
38
0.270
Why?
Antibodies, Monoclonal, Humanized
4
2012
663
0.220
Why?
Smallpox Vaccine
1
2003
22
0.220
Why?
Quality of Life
5
2021
2353
0.190
Why?
Transcranial Direct Current Stimulation
1
2021
4
0.190
Why?
Clinical Trials, Phase IV as Topic
1
2021
3
0.190
Why?
Tablets
1
2021
36
0.180
Why?
Glatiramer Acetate
2
2019
20
0.180
Why?
Motor Disorders
1
2021
17
0.180
Why?
Observational Studies as Topic
1
2021
90
0.180
Why?
JC Virus
1
2020
23
0.170
Why?
Rituximab
2
2019
150
0.170
Why?
Cerebellar Diseases
1
2020
21
0.170
Why?
Multicenter Studies as Topic
1
2021
249
0.170
Why?
Capsid Proteins
1
2020
69
0.170
Why?
Administration, Oral
1
2021
728
0.160
Why?
Humans
19
2021
114709
0.150
Why?
Magnetic Resonance Imaging
5
2021
3053
0.130
Why?
Phosphodiesterase Inhibitors
1
2016
82
0.130
Why?
Brain
6
2021
2371
0.130
Why?
Prospective Studies
2
2021
6220
0.120
Why?
Bacterial Vaccines
1
2014
61
0.110
Why?
Pyridines
1
2016
425
0.110
Why?
Viral Vaccines
1
2014
88
0.100
Why?
Adjuvants, Immunologic
1
2014
206
0.100
Why?
Autoimmune Diseases
1
2015
382
0.100
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
82
0.090
Why?
Mobility Limitation
1
2011
60
0.090
Why?
Nerve Regeneration
1
2010
50
0.090
Why?
Autoimmunity
1
2015
813
0.080
Why?
Secondary Prevention
1
2010
222
0.080
Why?
Disease Progression
2
2016
2381
0.080
Why?
Male
4
2021
55609
0.070
Why?
Peptides
1
2011
848
0.060
Why?
Female
5
2021
59523
0.060
Why?
Practice Guidelines as Topic
1
2011
1395
0.050
Why?
Age Factors
1
2010
2894
0.050
Why?
Double-Blind Method
2
2019
1660
0.050
Why?
Adult
5
2021
30554
0.050
Why?
Severity of Illness Index
1
2010
2540
0.050
Why?
Middle Aged
4
2021
26738
0.050
Why?
Neurophysiology
1
2021
13
0.050
Why?
Atrophy
1
2021
152
0.050
Why?
Young Adult
2
2021
10472
0.050
Why?
Transcranial Magnetic Stimulation
1
2021
44
0.040
Why?
Biomarkers
1
2010
3408
0.040
Why?
Treatment Outcome
2
2011
9088
0.040
Why?
Time Factors
1
2010
6116
0.040
Why?
Animals
3
2014
31709
0.040
Why?
Maintenance Chemotherapy
1
2019
22
0.040
Why?
Induction Chemotherapy
1
2019
56
0.040
Why?
Lower Extremity
1
2021
335
0.040
Why?
Risk Factors
1
2010
8634
0.040
Why?
Incidence
1
2003
2313
0.030
Why?
Diffusion Tensor Imaging
1
2016
63
0.030
Why?
B-Lymphocytes
2
2011
766
0.030
Why?
United States
1
2011
12186
0.030
Why?
Maximum Tolerated Dose
1
2011
183
0.020
Why?
Research Design
1
2016
928
0.020
Why?
Dendritic Cells
1
2011
435
0.020
Why?
CD8-Positive T-Lymphocytes
1
2012
688
0.020
Why?
T-Lymphocytes
1
2011
1737
0.010
Why?
Adolescent
1
2021
17855
0.010
Why?
Aged
1
2020
19074
0.010
Why?
Miravalle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)